Epatite B - Siematologia

Vai ai contenuti

Menu principale:

Epatite B

LINEE GUIDA > Linee Guida > capitolo10
infezioniLG10
infezionilg10-1-6
REFERENZE >> TUTTI i Pazienti in trattamento steroideo Immunosoppressivo,... REFERENZE >> HBV-DNA- HBV-DNA+ HBsAg-&HBcAb+ HBsAg-&HBcAb- HBsAg+ SCREENING 1° Livello: HBcAb, HBsAg, GOT, GPT, ALP, GGT, Br+...
 
•The SIE Experts recommend front-line antiviral prophylactic drugs against HBV for HBsAg-negative/anti-HBc-positive patients who are at high or moderate risk for reactivation.
 
•EASL Clinical Practice Guidelines (Journal of Hepatology 2012; 57: 167-185) and A.I.S.F. (Digestive and Liver Disease 2007; 39: 397-408)
 
•The SIE Experts suggests use of lamivudine (100 mg orally every day) over antiviral drugs with a high barrier to resistance for prophylaxis against HBV in HBsAg-negative/anti-HBc-positive patients who are at high or moderate-risk of reactivation.
 
•EASL Clinical Practice Guidelines (Journal of Hepatology 2012; 57: 167-185), and A.I.S.F. (Digestive and Liver Disease 2007; 39: 397-408)
 
•The SIE Experts suggest against routinely using antiviral prophylaxis in patients HBsAg-negative/anti-HBc-positive who are at low risk for reactivation.
 
•Expert Opinion
Torna ai contenuti | Torna al menu